BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 6437000)

  • 1. [Coagulation factors. Indications and applications].
    Stampfli K; Hartmann S
    Ther Umsch; 1984 Aug; 41(8):571-5. PubMed ID: 6437000
    [No Abstract]   [Full Text] [Related]  

  • 2. [Advances in the field of hemophilia therapy].
    Loeliger EA; Veltkamp JJ
    Ned Tijdschr Geneeskd; 1968 Sep; 112(36):1593-5. PubMed ID: 5680135
    [No Abstract]   [Full Text] [Related]  

  • 3. Recombinant blood clotting proteins for hemophilia therapy.
    Limentani SA; Roth DA; Furie BC; Furie B
    Semin Thromb Hemost; 1993; 19(1):62-72. PubMed ID: 8456325
    [No Abstract]   [Full Text] [Related]  

  • 4. [Substitution therapy of hemorrhagic diseases].
    Haupt H
    Anasthesiol Intensivmed Prax; 1975 Oct; 11(1):137-44. PubMed ID: 1225069
    [No Abstract]   [Full Text] [Related]  

  • 5. Recombinant antihemophilic factors.
    Kurachi K
    Biotechnology; 1991; 19():177-95. PubMed ID: 1786471
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemophiliacs with inhibitors: therapeutic options.
    Roberts HR
    N Engl J Med; 1981 Sep; 305(13):757-8. PubMed ID: 6790992
    [No Abstract]   [Full Text] [Related]  

  • 7. [Concentrated antihemophilic globulin in the treatment of hemorrhagic syndromes].
    Baklaja F; Cvetković V; Stajić M; Krivokapić L
    Bilt Hematol Transfuz; 1976; 4(3):61-6. PubMed ID: 1008799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial: Factor VIII inhibitors.
    Deykin D
    N Engl J Med; 1974 Jul; 291(4):205. PubMed ID: 4834491
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of hemophiliacs with inhibitors].
    Fujimaki M
    Rinsho Ketsueki; 1985 Jul; 26(7):1059-68. PubMed ID: 3932719
    [No Abstract]   [Full Text] [Related]  

  • 10. [Substitution therapy with factor 8 and factor IX preparations].
    Landbeck G
    Hamatol Bluttransfus; 1968; 5():29-42. PubMed ID: 5729465
    [No Abstract]   [Full Text] [Related]  

  • 11. Transfusion therapy in congenital coagulopathies.
    Lusher JM
    Hematol Oncol Clin North Am; 1994 Dec; 8(6):1167-80. PubMed ID: 7860443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Blood plasma fractions for the management of coagulation disorders: 3. The P.P.S.B. fraction].
    Richter K; Klingenberg K; Reinecke D
    Z Gesamte Inn Med; 1968 Jan; 23(1):18-21. PubMed ID: 5662427
    [No Abstract]   [Full Text] [Related]  

  • 13. Transfusion support for haemophiliacs.
    Allain JP
    Clin Haematol; 1984 Feb; 13(1):99-117. PubMed ID: 6426835
    [No Abstract]   [Full Text] [Related]  

  • 14. [Substitution therapy of coagulopathies].
    Beeser H; Egli H
    Infusionstherapie (1973); 1974 Aug; 1(6):447-53. PubMed ID: 4466806
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of blood products and factor concentrates for coagulation therapy.
    Fritsma MG
    Clin Lab Sci; 2003; 16(2):115-9. PubMed ID: 12757192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The management of patients with bleeding disorders.
    Wyld PJ; Dawson KP
    N Z Med J; 1984 Feb; 97(750):118-9. PubMed ID: 6424072
    [No Abstract]   [Full Text] [Related]  

  • 17. Current concepts in diagnosis and management of hemophilia.
    Aledort LM
    Hosp Pract (Off Ed); 1982 Oct; 17(10):77-84, 89-92. PubMed ID: 6811410
    [No Abstract]   [Full Text] [Related]  

  • 18. [Inhibitor hemophilia in oral surgery].
    Schulz S
    Zahn Mund Kieferheilkd Zentralbl; 1984; 72(8):824-8. PubMed ID: 6240865
    [No Abstract]   [Full Text] [Related]  

  • 19. Surgery in haemophilic patients with inhibitors.
    Rodriguez-Merchan EC
    Haemophilia; 2004 Sep; 10 Suppl 2():1-2. PubMed ID: 15385039
    [No Abstract]   [Full Text] [Related]  

  • 20. New alternatives and strategies in the treatment of inhibitors.
    Hoyer LW
    Prog Clin Biol Res; 1984; 150():367-72. PubMed ID: 6431440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.